Literature DB >> 3102493

Atypical glycosylation of an IgG monoclonal cryoimmunoglobulin.

C R Middaugh, G W Litman.   

Abstract

The NH2-terminal amino acid sequence of the heavy chain of the IgG monoclonal cryoimmunoglobulin Ger was determined. Evidence for the glycosylation of the first heavy chain hypervariable region of this protein was found. The inability of the deglycosylated Fab fragment of Ger to inhibit cryoprecipitation provides direct evidence that the presence of an additional sialic acid residue in a heavy chain's first hypervariable region can account for the cryo properties of this protein. This is the first convincing description of a molecular defect that explains the atypical low temperature solubility of a monoclonal cryoimmunoglobulin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3102493

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  An experimental model of cryoglobulin-associated vasculitis in mice.

Authors:  Y Pastore; F Lajaunias; A Kuroki; T Moll; S Kikuchi; S Izui
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Antibody variable region glycosylation: biochemical and clinical effects.

Authors:  A Wright; S L Morrison
Journal:  Springer Semin Immunopathol       Date:  1993

Review 3.  The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis.

Authors:  T W Rademacher; R B Parekh; R A Dwek; D Isenberg; G Rook; J S Axford; I Roitt
Journal:  Springer Semin Immunopathol       Date:  1988

Review 4.  Cryoglobulins.

Authors:  C Ferri; A L Zignego; S A Pileri
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

5.  High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation.

Authors:  Mohammad A Alsenaidy; Jae Hyun Kim; Ranajoy Majumdar; David D Weis; Sangeeta B Joshi; Thomas J Tolbert; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2013-09-24       Impact factor: 3.534

6.  Variable domain-linked oligosaccharides of a human monoclonal IgG: structure and influence on antigen binding.

Authors:  H Leibiger; D Wüstner; R D Stigler; U Marx
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

7.  IgG3 cryoglobulins in autoimmune MRL-lpr/lpr mice: immunopathogenesis, therapeutic approaches and relevance to similar human diseases.

Authors:  S Izui; T Berney; T Shibata; T Fulpius
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

8.  Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody.

Authors:  T P Patel; R B Parekh; B J Moellering; C P Prior
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

9.  Origin of the isoelectric heterogeneity of monoclonal immunoglobulin h1B4.

Authors:  P K Tsai; M W Bruner; J I Irwin; C C Ip; C N Oliver; R W Nelson; D B Volkin; C R Middaugh
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

Review 10.  Impact of Glycosylation on Effector Functions of Therapeutic IgG.

Authors:  Riad Abès; Jean-Luc Teillaud
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.